Zhejiang Shouxiangu Pharmaceutical Co., Ltd. (SHA:603896)
China flag China · Delayed Price · Currency is CNY
17.20
-0.34 (-1.94%)
May 12, 2026, 3:00 PM CST

SHA:603896 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
649.75778.39854.031,5041,525677.98
Trading Asset Securities
408.33356.16344.69-30130
Cash & Short-Term Investments
1,0581,1351,1991,5041,555807.98
Cash Growth
-3.65%-5.35%-20.30%-3.26%92.42%12.34%
Accounts Receivable
103.5894.09114.72113.06137.68117.25
Other Receivables
3.813.873.153.252.513.36
Receivables
107.3997.95117.87116.32140.19120.61
Inventory
219.74208.91181.69157.83147.7699.06
Other Current Assets
29.8529.1422.3728.7319.3517.64
Total Current Assets
1,4151,4711,5211,8071,8621,045
Property, Plant & Equipment
1,1131,111916.38682.32601.14515.91
Long-Term Investments
101.29102.6794.8565.7163.866.46
Other Intangible Assets
351.95354.28352.86310.9878.1682.98
Long-Term Deferred Tax Assets
1.651.69---0.37
Long-Term Deferred Charges
68.6173.8168.8279.7853.1339.93
Other Long-Term Assets
167.13167.42178.24228.71197.94211.51
Total Assets
3,2183,2823,1323,1742,8561,962
Accounts Payable
130.8154.78132.86132.71103.98107.94
Accrued Expenses
21.4665.6637.5640.2871.1554.03
Short-Term Debt
140194.04187.4372.16272.97-
Current Portion of Leases
-17.4516.7712.084.875.63
Current Income Taxes Payable
121.8285.64-0.020.240.02
Current Unearned Revenue
14.3714.9611.7410.19.039.61
Other Current Liabilities
6.3413.3717.7915.5322.05
Total Current Liabilities
451.51545.83393.33585.15477.77199.28
Long-Term Debt
389.08382.49361.01340.19412.5987.6
Long-Term Leases
18.662122.9323.9715.9713.33
Long-Term Unearned Revenue
58.7262.1354.8649.9841.338.23
Long-Term Deferred Tax Liabilities
9.449.648.393.783.043.98
Total Liabilities
927.411,021840.521,003950.67342.41
Common Stock
198.24198.24198.24201.83197.2152.5
Additional Paid-In Capital
818.22818.22821.52966.03856.25900.22
Retained Earnings
1,1491,1181,1531,076908.45690.99
Treasury Stock
----165.11-165.11-165.11
Comprehensive Income & Other
124.12125.23118.1592.83108.7341.06
Total Common Equity
2,2892,2602,2912,1711,9061,620
Minority Interest
1.90.93---0.38
Shareholders' Equity
2,2912,2602,2912,1711,9061,620
Total Liabilities & Equity
3,2183,2823,1323,1742,8561,962
Total Debt
564.45614.98588.11748.4706.41106.56
Net Cash (Debt)
493.62519.57610.61755.56848.31701.42
Net Cash Growth
-17.22%-14.91%-19.18%-10.93%20.94%32.06%
Net Cash Per Share
2.472.573.083.864.373.67
Filing Date Shares Outstanding
192.87198.24198.24198.24197.2198.25
Total Common Shares Outstanding
192.87198.24198.24198.24197.2198.25
Working Capital
963.55924.721,1271,2221,384846.02
Book Value Per Share
11.8711.4011.5610.959.668.17
Tangible Book Value
1,9371,9051,9381,8601,8271,537
Tangible Book Value Per Share
10.049.619.789.389.277.75
Buildings
-858.76350.9308.29357.46355.62
Machinery
-305251.39241.18198.58145.46
Construction In Progress
-192.72501.72280.21169.63115.34
Source: S&P Global Market Intelligence. Standard template. Financial Sources.